Pathogenicity of the highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans and its geographic dissemination and role in aggressive periodontitis

Journal of Oral Microbiology

Volumn 6, Issue 1, 2014, Pages

  Haubek, Dorte ^a   Johansson, Anders ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Cytolethal distending toxin; Geographical dissemination; Host response; Leukotoxin; Spreading; Virulence factors

Indexed keywords

CYTOLETHAL DISTENDING TOXIN; LEUKOTOXIN;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CELL CYCLE ARREST; DISEASE SEVERITY; DISEASE TRANSMISSION; ENDOTHELIUM CELL; ERYTHROCYTE; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOGENICITY; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; LYMPHOCYTE COUNT; MOLECULAR CLONING; NEUTROPHIL; NONHUMAN; OPERON; PATHOGENICITY; PERIODONTITIS; POLYMERASE CHAIN REACTION; POPULATION GENETICS; TYPE I SECRETION SYSTEM;

EID: 84924133554     PISSN: None     EISSN: 20002297     Source Type: Journal    
DOI: 10.3402/jom.v6.23980     Document Type: Article

References (220)

1. Slots J. The predominant cultivable organisms in juvenile periodontitis. Scand J Dent Res 1976; 84: 1-10.
2. Slots J, Zambon JJ, Rosling BG, Reynolds HS, Christersson LA, Genco RJ. Actinobacillus actinomycetemcomitans in human periodontal disease. Association, serology, leukotoxicity, and treatment. J Periodontal Res 1982; 17: 447-8.
3. Zambon JJ, Christersson LA, Slots J. Actinobacillus actinomycetemcomitans in human periodontal disease. Prevalence in patient groups and distribution of biotypes and serotypes within families. J Periodontol 1983; 54: 707-11.
4. Zambon JJ. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 1985; 12: 1-20.
5. Tsai C-C, Taichman S. Dynamics of infection by leukotoxic strains of Actinobacillus actinomycetemcomitans in juvenile periodontitis. J Clin Periodontol 1986; 11: 330-1.
6. Henderson B, Ward JM, Ready D. Aggregatibacter (Actinobacillus) actinomycetemcomitans: a triple A* periopathogen? Periodontol 2000 2010; 54: 78-105.
7. Baehni PC, Tsai C-C, McArthur WP, Hammond BF, Shenker BJ, Taichman NS. Leukotoxic activity in different strains of the bacterium Actinobacillus actinomycetemcomitans isolated from juvenile periodontitis in man. Arch Oral Biol 1981; 26: 671-6.
8. Fives-Taylor PM, Meyer DH, Mintz KP, Brissette C. Virulence factors of Actinobacillus actinomycetemcomitans. Periodontol 2000 1999; 20: 136-67.
9. Lally ET, Hill RB, Kieba IR, Korostoff J. The interaction between RTX toxins and target cells. Trends Microbiol 1999; 7: 356-61.
10. Johansson A, Sandström G, Claesson R, Hänström L, Kalfas S. Anaerobic neutrophil-dependent killing of Actinobacillus actinomycetemcomitans in relation to the bacterial leukotoxicity. Eur J Oral Sci 2000A; 108: 136-46.
11. Johansson A, Claesson R, Hänström L, Sandström G, Kalfas S. Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans. J Periodontal Res 2000B; 35: 85-92.
12. Johansson A. Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response. Toxins 2011; 3: 242-59.
13. Lally ET, Kieba IR, Demuth DR, Rosenbloom J, Golub EE, Taichman NS, et al. Identification and expression of the Actinobacillus actinomycetemcomitans leukotoxin gene. Biochem Biophys Res Commun 1989; 159: 256-62.
14. Spitznagel J, Kraig E, Kolodrubetz D. Regulation of leukotoxin and nonleukotoxic strains of Actinobacillus actinomycetemcomitans. Infect Immun 1991; 59: 1394-401.
15. Spitznagel J, Kraig E, Kolodrubetz D. The regulation of leukotoxin production in Actinobacillus actinomycetemcomitans strain JP2. Adv Dent Res 1995; 9: 48-54.
16. Lally ET, Golub EE, Kieba IR, Taichman NS, Decker S, Berthold P, et al. Structure and function of the B and D genes of the Actinobacillus actinomycetemcomitans leukotoxin complex. Microb Pathog 1991; 11: 111-21.
17. Lally ET, Kieba IR. Molecular biology of Actinobacillus actinomycetemcomitans leukotoxin. In: Genco R, ed. Molecular pathogenesis of periodontal disease. Washington, DC: ASM Press; 1994. p. 69-82.
18. Lally ET, Kieba IR, Golub EE, Lear JD, Tanaka JC. Structure/function aspects of Actinobacillus actinomycetemcomitans leukotoxin. J Periodontol 1996; 67: 298-308.
19. Lally ET, Kieba IR, Sato A, Green CL, Rosenbloom J, Korostoff J, et al. RTX toxins recognize a beta 2 integrin on the surface of human target cells. J Biol Chem 1997; 272: 30463-9.
20. Kachlany SC, Fine DH, Figurski DH. Secretion of RTX leukotoxin by Actinobacillus actinomycetemcomitans. Infect Immun 2000; 68: 6094-100.
21. Fine DH, Kaplan JB, Kachlany SC, Schreiner HC. How we got attached to Actinobacillus actinomycetemcomitans: a model for infectious diseases. Periodontol 2000 2006; 42: 114-57.
22. Kachlany SC. Aggregatibacter actinomycetemcomitans leukotoxin: from treat to therapy. J Dent Res 2010; 89: 561-70.
23. Poulsen K, Theilade E, Lally ET, Demuth DR, Kilian M. Population structure of Actinobacillus actinomycetemcomitans: a framework for studies of disease-associated properties. Microbiology 1994; 140: 2049-60.
24. Haubek D, Poulsen K, Asikainen S, Kilian M. Evidence for absence in Northern Europe of especially virulent clonal types of Actinobacillus actinomycetemcomitans. J Clin Microbiol 1995; 33: 395-401.
25. Kaplan JB, Schreiner HC, Furgang D, Fine DH. Population structure and genetic diversity of Actinobacillus actinomycetemcomitans strains isolated from localized juvenile periodontitis patients. J Clin Microbiol 2002; 40: 1181-7.
26. Kilian M, Frandsen EV, Haubek D, Poulsen K. The etiology of periodontal disease revisited by population genetic analysis. Periodontol 2000 2006; 42: 158-79.
27. Haubek D, Poulsen K, Westergaard J, Dahlén G, Kilian M. Highly toxic clone of Actinobacillus actinomycetemcomitans in geographically widespread cases of juvenile periodontitis in adolescents of African origin. J Clin Microbiol 1996; 34: 1576-8.
28. Brogan JM, Lally ET, Poulsen K, Kilian M, Demuth DR. Regulation of Actinobacillus actinomycetemcomitans leukotoxin expression: analysis of the promoter regions of leukotoxic and minimally leukotoxic strains. Infect Immun 1994; 62: 501-8.
29. Haubek D, Poulsen K, Kilian M. Microevolution and patterns of dissemination of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans. Infect Immun 2007; 25: 3080-8.
30. Haubek D, DiRienzo JM, Tinoco EM, Westergaard J, López NJ, Chung CP. Racial tropism of a highly toxic clone of Actinobacillus actinomycetemcomitans associated with juvenile periodontitis. J Clin Microbiol 1997; 35: 3037-42.
31. Haubek D. The highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans: evolutionary aspects, epidemiology and etiological role in aggressive periodontitis. APMIS Suppl 2010; 130: 1-53.
32. Haubek D, Ennibi OK, Poulsen K, Poulsen K, Benzarti N, Kilian M. Early-onset periodontitis in Morocco is associated with the highly leukotoxic clone of Actinobacillus actinomycetemcomitans. J Dent Res 2001; 80: 1580-3.
33. Haubek D, Ennibi OK, Poulsen K, Vaeth M, Poulsen S, Kilian M. Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study. Lancet 2008; 371: 237-42.
34. Åberg CH, Kwamin F, Claesson R, Johansson A, Haubek D. Presence of JP2 and non-JP2 genotypes of Aggregatibacter actinomycetemcomitans and attachment loss in adolescents in Ghana. J Periodontol 2012; 83: 1520-8.
35. Höglund Åberg C, Kwamin F, Claesson R, Dahlén G, Johansson A, Haubek D. Progression of attachment loss is strongly associated with presence of the JP2 genotype of Aggregatibacter actinomycetemcomitans: a prospective cohort study of a young adolescent population. J Clin Periodontol 2014; 41: 232-41.
36. Albandar JM, Brown LJ, Genco RJ, Löe H. Clinical classification of periodontitis in adolescents and young adults. J Periodontol 1997; 68: 545-55.
37. Jenkins WM, Papapanou PN. Epidemiology of periodontal disease in children and adolescents. Periodontol 2000 2001; 26: 16-32.
38. Albandar JM, Tinoco EMB. Global epidemiology of periodontal diseases in children and young persons. Periodontol 2000 2002; 29: 153-76.
39. Baelum V, Scheutz F. Periodontal disease in Africa. Periodontol 2000 2002; 29: 79-103.
40. Lopez R, Baelum V. Classifying periodontitis among adolescents: implications for epidemiological research. Commun Dent Oral Epidemiol 2003; 31: 136-46.
41. Rylev M, Kilian M. Prevalence and distribution of principal periodontal pathogens worldwide. J Clin Periodontol 2008; 35: 346-61.
42. Albandar JM, Buischi YA, Barbosa MF. Destructive forms of periodontal disease in adolescents. A 3-year longitudinal study. J Periodontol 1991; 62: 370-6.
43. Bueno LC, Mayer MPA, DiRienzo JM. Relationship between conversion of localized juvenile periodontitis-susceptible children from health to disease and Actinobacillus actinomycetemcomitans leukotoxin promoter structure. J Periodontol 1998; 69: 998-1007.
44. Albandar JM, Kingman A, Jackson Brown L, Löe H. Gingival inflammation and subgingival calculus as determinants of disease progression in early-onset periodontitis. J Clin Periodontol 1998; 25: 231-7.
45. Stabholz A, Mann J, Agmon A, Soskolne WA. The description of a unique population with a very high prevalence of localized juvenile periodontitis. J Clin Periodontol 1998; 25: 872-8.
46. Levin L, Baev V, Lev R, Stabholz A, Ashkenazi M. Aggressive periodontitis among young Israeli army personnel. J Periodontol 2006; 77: 1392-6.
47. Elamin AM, Skaug N, Ali RW, Bakken V, Albandar JM. Ethnic disparities in the prevalence of periodontitis among high school students in Sudan. J Periodontol 2010; 81: 891-6.
48. Saxen L. Prevalence of juvenile periodontitis in Finland. J Clin Periodontol 1980; 7: 177-86.
49. Kronauer E, Borsa G, Lang NP. Prevalence of incipient juvenile periodontitis at age 16 years in Switzerland. J Clin Periodontol 1986; 13: 103-8.
50. Löe H, Brown LJ. Early onset periodontitis in the United States of America. J Periodontol 1991; 62: 608-16.
51. Melvin WL, Sandifer JB, Gray JL. The prevalence and sex ratio of juvenile periodontitis in a young racially mixed population. J Periodontol 1991; 62: 330-4.
52. Harley AF, Floyd PD. Prevalence of juvenile periodontitis in school children in Lagos, Nigeria. Community Dent Oral Epidemiol 1988; 16: 299-301.
53. Albandar JM, Muranga MB, Rams TE. Prevalence of aggressive periodontitis in school attendees in Uganda. J Clin Periodontol 2002; 29: 823-33.
54. Kinane DF, Shiba H, Hart TC. The genetic basis of periodontitis. Periodontol 2000 2005; 39: 91-117.
55. Kinane DF, Peterson M, Stathopoulou PG. Environmental and other modifying factors of the periodontal diseases. Periodontol 2000 2006; 40: 107-19.
56. Orru` G, Marini MF, Cuisa ML, Isola D, Cotti M, Baldoni M, et al. Usefulness of real time PCR for the differentiation and quantification of 652 and JP2 Actinobacillus actinomycetemcomitans genotypes in dental plaque and saliva. BMC Infect Dis 2006; 6: 98.
57. Claesson R. Detection of JP2 and non-JP2 clonal types of Aggregatibacter actinomycetemcomitans in clinical samples analysed at the microbiological laboratory in Dental School in Umeå, Sweden. Abstract presented at Europerio 2012, unpublished data, Vienna, Austria; 6-9 June 2012.
58. DiRienzo JM, Slots J, Sixou M, Sol MA, Harmon R, McKay TL. Specific genetic variants of Actinobacillus actinomycetemcomitans correlate with disease and health in a regional population of families with localized juvenile periodontitis. Infect Immun 1994; 62: 3058-65.
59. Zambon JJ, Haraszthy VI, Hariharan G, Lally ET, Demuth DR. The microbiology of early-onset periodontitis: Association of highly toxic Actinobacillus actinomycetemcomitans with localized juvenile periodontitis. J Periodontol 1996; 67: 282-90.
60. Haraszthy VI, Hariharan G, Tinoco EM, Cortelli JR, Lally ET, Davis E, et al. Evidence for the role of highly leukotoxic Actinobacillus actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of early-onset periodontitis. J Periodontol 2000; 71: 912-22.
61. Tinoco EMB, Beldi MI, Loureiro CA, Lana M, Campedelli F, Tinoco NMB, et al. Localized juvenile periodontitis and Actinobacillus actinomycetemcomitans in a Brazilian population. Eur J Oral Sci 1997; 105: 9-14.
62. Saarela M, Saxen L, Slots J. Clonal specificity of Actinobacillus actinomycetemcomitans in destructive periodontal disease. Clin Infect Dis 1997; 25: S227-S9.
63. Macheleidt A, Müller H-P, Eger T, Putzker M, Fuhrmann A, Zöller L. Absence of an especially toxic clone among isolates of Actinobacillus actinomycetemcomitans recovered from army recruits. Clin Oral Invest 1999; 3: 161-7.
64. Mombelli A, Gmür R, Lang NP, Corbet E, Frey J. Actinobacillus actinomycetemcomitans in Chinese adults. Serotypes distribution and analysis of the leukotoxin gene promoter locus. J Clin Periodontol 1999; 26: 505-10.
65. He T, Nishihara T, Demuth DR, Ishikawa I. A novel insertion sequence increases the expression of leukotoxicity in Actinobacillus actinomycetemcomitans clinical isolates. J Periodontol 1999; 70: 1261-8.
66. Contreras A, Rusitanonta T, Chen C, Wagner WG, Michalowicz BS, Slots J. Frequency of 530-bp deletion in Actinobacillus actinomycetemcomitans leukotoxin promoter region. Oral Microbiol Immunol 2000; 15: 338-40.
67. Tan KS, Woo CH, Ong G, Song KP. Prevalence of Actinobacillus actinomycetemcomitans in an ethnic adult Chinese population. J Clin Periodontol 2001; 28: 886-90.
68. Müller HP, Heinecke A, Fuhrmann A, Eger T, Zoller L. Intraoral distribution of Actinobacillus actinomycetemcomitans in young adults with minimal periodontal disease. J Periodontal Res 2001; 36: 114-23.
69. Saddi-Ortega L, Carvalho MAR, Cisalpino PS, Moreira ESA. Actinobacillus actinomycetemcomitans genetic heterogeneity: amplification of JP2-like ltx promoter pattern correlated with specific arbitrarily primed polymerase chain reaction (AP-PCR) genotypes from human but not marmoset Brazilian isolates. Can J Microbiol 2002; 48: 602-10.
70. Cortelli SC, Jorge AOC, Cortelli JR, Jordan SF, Haraszthy VI. Detection of highly and minimally leukotoxic Actinobacillus actinomycetemcomitans strains in patients with periodontal disease. Pesqui Odontol Bras 2003; 17: 183-8.
71. Cortelli JR, Cortelli SC, Jordan S, Haraszthy VI, Zambon JJ. Prevalence of periodontal pathogens in Brazilians with aggressive or chronic periodontitis. J Clin Periodontol 2005; 32: 860-6.
72. Leung WK, Ngai VK, Yau JY, Cheung BP, Tsang PW, Corbet EF. Characterization of Actinobacillus actinomycetemcomitans isolated from Chinese aggressive periodontitis patients. J Periodont Res 2005; 40: 258-68.
73. Junior WR, de Andrade AFB, Colombo APV. Prevalence of leukotoxic genotypes of Actinobacillus actinomycetemcomitans in Brazilians with chronic periodontitis. Braz J Microbiol 2006; 37: 590-6.
74. Fine DH, Markowitz K, Furgang D, Fairlie K, Ferrandiz J, Nasri C, et al. Aggregatibacter actinomycetemcomitans and its relationship to initiation of localized aggressive periodontitis: longitudinal cohort study of initially healthy adolescents. J Clin Microbiol 2007; 45: 3859-69.
75. Van der Reijden WA, Bosch-Tijhof CJ, van der Velden U, van Winkelhoff AJ. Java project on periodontal diseases: serotype distribution of Aggregatibacter actinomycetemcomitans and serotype dynamics over an 8-year period. J Clin Periodontol 2008; 35: 487-92.
76. Viera EMM, Raslan SA, Wahasugui TC, Avila-Campos MJ, Marville V, Gaetti-Jardim Junior E. Occurrence of Aggregatibacter actinomycetemcomitans in Brazilian Indians from Ulutina reservation, Mato Grosso, Brazil. JAppl Oral Sci 2009; 17: 440-5.
77. Sakellari D, Katsikari A, Slini T, Ioannidis I, Konstantinidis A, Arsenakis M. Prevalence and distribution of Aggregatibacter actinomycetemcomitans serotypes and the JP2 clone in a Greek population. J Clin Periodontol 2011; 38: 108-14.
78. Bandhaya P, Saraithong P, Likittanasombat K, Hengprasith B, Torrungruang K Aggregatibacter actinomycetemcomitans serotypes, the JP2 clone and cytolethal distending toxin genes in a Thai population. J Clin Periodontol 2012; 39: 519-25.
79. Martinez-Martinez RE, Loyola-Rodriguez JP, Bonilla-Garro SE, Patino-Marin N, Haubek D, Amano A, et al. Characterization of periodontal biofilm in Down syndrome patients: a comparative study. J Clin Pediatr Dent 2013; 37: 298-95.
80. Wahasugui TC, Nakano V, Piazza RM, Avila-Campos MJ. Phenotypic and genotypic features of Aggregatibacter actinomycetemcomitans isolated from patients with periodontal disease. Diag Microbiol Infect 2013; 75: 366-72.
81. Haubek D, Ennibi OK, Poulsen K, Benzarti N, Baelum V. The highly leukotoxic JP2 clone of Actinobacillus actinomycetemcomitans and progression of periodontal attachment loss. J Dent Res 2004; 83: 767-70.
82. Haubek D, Ennibi O-K, Abdellaoui L, Benzarti N, Poulsen S. Attachment loss in Moroccan early onset periodontitis patients and infection with the JP2-type of Actinobacillus actinomycetemcomitans. J Clin Periodontol 2002; 29: 657-60.
83. Van der Velden U, Abbas F, Van Steenbergen TJ, De Zoete OJ, Hesse M, De RC, et al. Prevalence of periodontal breakdown in adolescents and presence of Actinobacillus actinomycetemcomitans in subjects with attachment loss. J Periodontol 1989; 60: 604-10.
84. Van der Velden U, Abbas F, Armand S, Loos B, Timmerman MF, Van der Weijden GA, et al. Java project on periodontal diseases. The natural development of periodontitis: risk factors, risk predictors and risk determinants. J Clin Periodontol 2006; 33: 540-8.
85. Haubek D, Havemose-Poulsen A, Westergaard J. Aggressive periodontitis in a 16-year-old Ghanaian adolescent, the original source of Actinobacillus actinomycetemcomitans strain HK 1651- a 10-year follow up. Int J Paediatr Dent 2006; 16: 370-5.
86. Addo-Yobo C, Williams SA, Curzon ME. Oral hygiene practices, oral cleanliness and periodontal treatment needs in 12-year old urban and rural school children in Ghana. Community Dent Health 1991; 8: 155-62.
87. Slots J, Ting M. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontol 2000 1999; 20: 82-121.
88. Alaluusua S, Asikainen S, Lai CH. Intrafamilial transmission of Actinobacillus actinomycetemcomitans. J Periodontol 1991; 62: 207-1.
89. Alaluusua S, Jousimies-Somer H, Asikainen S. Ribotyping shows intrafamilial similarity in Actinobacillus actinomycetemcomitans isolates. Oral Microbiol Immunol 1993; 8: 225-9.
90. Petit MDA, van Steenbergen TJM, van der Velden U, De Graaff J. Epidemiology and transmission of Porphyromonas gingivalis and Actinobacillus actinomycetemcomitans among children and their family members. J Clin Periodontol 1993A; 20: 641-50.
91. Preus HR, Zambon JJ, Dunford RG, Genco RJ. The distribution and transmission of Actinobacillus actinomycetemcomitans in families with established adult periodontitis. J Periodontol 1994; 65: 2-7.
92. Asikainen S, Chen C, Slots J. Likelihood of transmitting Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in families with periodontitis. Oral Microbiol Immunol 1996; 11: 387-94.
93. Asikainen S, Chen C, Alaluusua S, Slots J. Can one acquire periodontal bacteria and periodontitis from a family member? J Am Dent Assoc 1997; 128: 1263-71.
94. Asikainen S, Chen C. Oral ecology and person-to-person transmission of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Periodontol 1999; 20: 65-81.
95. Haubek D, Westergaard J. Detection of a highly toxic clone of Actinobacillus actinomycetemcomitans (JP2) in a Moroccan immigrant family with multiple cases of localized aggressive periodontitis. Int J Paediatr Dent 2004; 14: 41-8.
96. Okada M, Hayashi F, Soda Y, Zhong X, Miura K, Kozai K. Intra-familial distribution of nine putative periodonto pathogens in dental plaque samples analyzed by PCR. J Oral Sci 2004; 46: 149-56.
97. Dogan B, Kipalev AS, Ökte E, Sultan N, Asikainen SE. Consistent intrafamilial transmission of Actinobacillus actinomycetemcomitans despite clonal diversity. J Periodontol 2008; 79: 307-15.
98. Saarela M, von Troil-Linden B, Torkko H, Stucki AM, Alaluusua S, Jousimies-Somer H, et al. Transmission of oral bacterial species between spouses. Oral Microbiol Immunol B 1993; 8: 349-54.
99. Petit MDA, van Steenbergen TJM, De Graaff J, van der Velden U. Transmission of Actinobacillus actinomycetemcomitans in families of adult periodontitis patients. J Periodontal Res B 1993; 28: 85-100.
100. van Winkelhoff AJ, Boutaga K. Transmission of periodontal bacteria and models of infection. J Clin Periodontol 2005; 32: 16-27.
101. Haubek D, Ismaili Z, Poulsen S, Ennibi O-K, Benzarti N, Baelum V. Association between sharing of toothbrushes, eating and drinking habits and the presence of Actinobacillus actinomycetemcomitans in Moroccan adolescents. Oral Microbiol Immunol 2005; 20: 195-8.
102. Saarela M, Asikainen S, Alaluusua S, Pyhälä L, Lai CH, Jousimies-Somer H. Frequency and stability of mono- or polyinfection by Actinobacillus actinomycetemcomitans serotypes a, b, c, d or e. Oral Microbiol Immunol 1992; 7: 277-9.
103. Saarela MH, Dogan B, Alaluusua S, Asikainen S. Persistence of oral colonization by the same Actinobacillus actinomycetemcomitans strain(s). J Periodontol 1999; 70: 504-9.
104. Lamell CW, Griffen AL, McClellan DL, Leys EJ. Acquisition and colonization stability of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in children. J Clin Microbiol 2000; 38: 1196-9.
105. Ooshima T, Nishiyama N, Hou B, Tamura K, Kusumoto A, Kimura S. Occurrence of periodontal bacteria in healthy children: a 2-year longitudinal study. Community Dent Oral Epidemiol 2003; 31: 417-25.
106. Sakai VT, Campos MR, Machado MA, Lauris JR, Greene AS, Santos CF. Prevalence of four putative periodontopathic bacteria in saliva of a group of Brazilian children with mixed dentition: 1-year longitudinal study. Int J Paediatr Dent 2007; 17: 192-9.
107. Kittichotirat W, Bumgarner RE, Asikainen S, Chen C. Identification of the pangenome and its components in 14 distinct Aggregatibacter actinomycetemcomitans strains by comparative genomic analysis. PLoS One 2011; 6: e22420.
108. Tsai C-C, Shenker BJ, DiRienzo JM, Malamud D, Taichman NS. Extraction and isolation of a leukotoxin from Actinobacillus actinomycetemcomitans with polymyxin B. Infect Immun 1984; 43: 700-5.
109. Haubek D, Ennibi OK, Vaeth M, Poulsen S, Poulsen K. Stability of the JP2 clone of Aggregatibacter actinomycetemcomitans. J Dent Res 2009; 88: 856-60.
110. Ennibi OK, Benrachadi L, Bouziane A, Haubek D, Poulsen K. The highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans in localized and generalized forms of aggressive periodontitis. Acta Odontol Scand 2012; 70: 318-22.
111. Claesson R, Lagervall M, Höglund Åberg C, Johansson A, Haubek D. Detection of the highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans in members of a Caucasian family living in Sweden. J. Clin Periodontol 2011; 38: 115-21.
112. Saarela M, Asikainen S, Jousimies-Somer H, Asikainen T, von Troil-Lindén B, Alaluusua S. Hybridization patterns of Actinobacillus actinomycetemcomitans serotypes a-e detected with an rRNA gene probe. Oral Microbiol Immunol A 1993; 8: 111-5.
113. Guthmiller JM, Lally ET, Korostoff J. Beyond the specific plaque hypothesis: are highly leukotoxic strains of Actinobacillus actinomycetemcomitans a paradigm for periodontal pathogenesis? Crit Rev Oral Biol Med 2001; 12: 116-24.
114. Loomer PM. Microbiological diagnostic testing in the treatment of periodontal diseases. Periodontol 2000 2004; 34: 49-56.
115. Poulsen K, Ennibi O-K, Haubek D. Improved PCR for detection of the highly leukotoxic JP2 clone of Actinobacillus actinomycetemcomitans in subgingival plaque samples. J Clin Microbiol 2003; 41: 4829-32.
116. Seki M, Poulsen K, Haubek D, Kilian M. A novel loopmediated isothermal amplification method for detection of the JP2 clone of Aggregatibacter actinomycetemcomitans in subgingival plaque. J Clin Microbiol 2008; 46: 1113-5.
117. Yoshida A, Ennibi OK, Miyazaki H, Hoshino T, Hayashida H, Nishihara T, et al. Quantitative discrimination of Aggregatibacter actinomycetemcomitans highly leukotoxic JP2 clone from non-JP2 clones in diagnosis of aggressive periodontitis. BMC Infect Dis 2012; 12: 253.
118. Slots J, Genco RJ. Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemco- mitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction. J Dent Res 1984; 63: 412-21.
119. Wilson M, Henderson B. Virulence factors of Actinobacillus actinomycetemcomitans relevant to the pathogenesis of inflammatory periodontal diseases. FEMS Microbiol Rev 1995; 17: 365-79.
120. Meyer DH, Fives-Taylor PM. The role of Actinobacillus actinomycetemcomitans in the pathogenesis of periodontal disease. Trends Microbiol 1997; 5: 224-8.
121. Hamada S, Amano A, Kimura S, Nakagawa I, Kawabata S, Morisaki I. The importance of fimbriae in the virulence and ecology of some oral bacteria. Oral Microbiol Immunol 1998; 13: 129-38.
122. Olsen I, Shah HN, Gharbia SE. Taxonomy and biochemical characteristics of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Periodontol 2000 1999; 20: 14-52.
123. Henderson B, Wilson M, Sharp L, Ward JM. Actinobacillus actinomycetemcomitans. J Med Microbiol 2002; 51: 1013-20.
124. Henderson B, Nair SP, Ward JM, Wilson M. Molecular pathogenicity of the oral opportunistic pathogen Actinobacillus actinomycetemcomitans. Annu Rev Microbiol 2003; 57: 29.
125. Fine DH, Figurski D, Kachlany SC, Kaplan J. Molecular windows into the pathogenic properties of Aggregatibacter actinomycetemcomitans: a status report with a view to the future. In: Rogers AH, ed. Molecular Oral Microbiology, p. 135-59. Norfork, UK: Caister Academic Press; 2008.
126. Tsai CC, McArthur WP, Baehni PC, Hammond BF, Taichman NS. Extraction and partial characterization of a leukotoxin from a plaque-derived Gram-negative microorganism. Infect Immun 1979; 25: 427-439.
127. Baehni P, Tsai CC, McArthur WP, Hammond BF, Taichman NS. Interaction of inflammatory cells and oral microorganisms. VIII. Detection of leukotoxic activity of a plaque-derived gram-negative microorganism. Infect Immun 1979; 24: 233-43.
128. Taichman NS, Dean RT, Sanderson CJ. Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans. Infect Immun 1980; 28: 258-68.
129. Mangan DF, Taichman NS, Lally ET, Wahl SM. Lethal effects of Actinobacillus actinomycetemcomitans leukotoxin on human T lymphocytes. Infect Immun 1991; 59: 3267-72.
130. Kelk P, Johansson A, Claesson R, Hanstrom L, Kalfas S. Caspase 1 involvement in human monocyte lysis induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 2003; 71: 4448-4455.
131. Balashova NV, Crosby JA, Al Ghofaily L, Kachlany SC. Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans. Infect Immun 2006; 74: 2015-2021.
132. Dietmann A, Millonig A, Combes V, Couraud PO, Kachlany SC, Grau GE. Effects of Aggregatibacter actinomycetemcomitans leukotoxin on endothelial cells. Microb Pathog 2013; 61-62: 43-50.
133. Schreiner H, Li Y, Cline J, Tsiagbe VK, Fine DH. A comparison of Aggregatibacter actinomycetemcomitans (Aa) virulence traits in a rat model for periodontal disease. PLoS One 2013; 8: e69382.
134. Kraig E, Dailey T, Kolodrubetz D. Nucleotide sequence of the leukotoxin gene from Actinobacillus actinomycetemcomitans: homology to the alpha-hemolysin/leukotoxin gene family. Infect Immun 1990; 58: 920-9.
135. Zambon JJ, Slots J, Genco RJ. Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease. Infect Immun 1983; 41: 19-27.
136. Lally ET, Golub EE, Kieba IR, Taichman NS, Rosenbloom J, Rosenbloom JC, et al. Analysis of the Actinobacillus actinomycetemcomitans leukotoxin gene. Delineation of unique features and comparison to homologous toxins. J Biol Chem 1989; 264: 15451-56.
137. Linhartová I, Bumba L, Mašín J, Basler M, Osička R, Kamanová J, et al. RTX proteins: a highly diverse family secreted by a common mechanism. FEMS Microbiol Rev 2010; 34: 1076-112.
138. Welch RA. RTX toxin structure and function: a story of numerous anomalies and few analogies in toxin biology. Curr Top Microbiol Immunol 2001; 257: 85-111.
139. Brown AC, Balashova NV, Epand RM, Epand RF, Bragin A, Kachlany SC, et al. Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition amino acid consensus (CRAC) site for membrane association. J Biol Chem 2013; 288: 23607-21.
140. Balashova NV, Shah C, Patel JK, Megalla S, Kachlany SC. Aggregatibacter actinomycetemcomitans LtxC is required for leukotoxin activity and initial interaction between toxin and host cells. Gene 2009; 443: 42-47.
141. Lally ET, Golub EE, Kieba IR. Identification and immunological characterization of the domain of Actinobacillus actinomycetemcomitans leukotoxin that determines its specificity for human target cells. J Biol Chem 1994; 269: 31289-95.
142. 2+ on the binding of Actinobacillus actinomycetemcomitans leukotoxin and the cytotoxicity to promyelocytic leukemia HL-60 cells. Biochem Mol Biol Int 1993; 29: 899-905.
143. Kuhnert P, Christensen H, editors. Pasteurellaceae biology, genomics and molecular aspects. Norfolk, UK: Caister Academic Press; 2008. p. 1-267.
144. Johansson A, Claesson R, Hänström L, Kalfas S. Serummediated release of leukotoxin from the cell surface of the periodontal pathogen Actinobacillus actinomycetemcomitans. Eur J Oral Sci 2003; 111: 209-215.
145. Tang G, Kawai T, Komatsuzawa H, Mintz KP. Lipopolysaccharides mediate leukotoxin secretion in Aggregatibacter actinomycetemcomitans. Mol Oral Microbiol 2012; 27: 70-82.
146. Brage M, Holmlund A, Johansson A. Humoral immune response to Aggregatibacter actinomycetemcomitans leukotoxin. J Periodontal Res 2011; 46: 170-5.
147. Dileepan T, Kachlany SC, Balashova NV, Patel J, Maheswaran SK. Human CD18 is the functional receptor for Aggregatibacter actinomycetemcomitans leukotoxin. Infect Immun 2007; 75: 4851-6.
148. Kieba IR, Fong KP, Tang HY, Hoffman KE, Speicher DW, Klickstein LB. Aggregatibacter actinomycetemcomitans leukotoxin requires beta-sheets 1 and 2 of the human CD11a betapropeller for cytotoxicity. Cell Microbiol 2007; 9: 2689-99.
149. Reinholdt J, Poulsen K, Brinkmann CR, Hoffmann SV, Stapulionis R, Enghild JJ, et al. Monodisperse and LPS-free Aggregatibacter actinomycetemcomitans leukotoxin: interactions with human b2 integrins and erythrocytes. Biochim Biophys Acta 2013; 1834: 546-58.
150. Dustin ML, Bivona TG, Philips MR. Membranes as messengers in T cell adhesion signaling. Nat Immunol 2004; 5: 363- 72.
151. Fong KP, Pacheco CM, Otis LL, Baranwal S, Kieba IR, Harrison G, et al. Actinobacillus actinomycetemcomitans leukotoxin requires lipid microdomains for target cell cytotoxicity. Cell Microbiol 2006; 8: 1753-67.
152. DiFranco KM, Gupta A, Galusha LE, Perez J, Nguyen TV, Fineza CD, et al. Leukotoxin (Leukothera®) targets active leukocyte function antigen-1 (LFA-1) protein and triggers a lysosomal mediated cell death pathway. J Biol Chem 2012; 287: 17618-27.
153. Hritz M, Fisher E, Demuth DR. Differential regulation of the leukotoxin operon in highly leukotoxic and minimally leukotoxic strains of Actinobacillus actinomycetemcomitans. Infect Immun 1996; 64: 2724-9.
154. Umeda JE, Longo PL, Simionato MR, Mayer MP. Differential transcription of virulence genes in Aggregatibacter actinomycetemcomitans serotypes. J Oral Microbiol 2013; 5. DOI: 10.3402/jom.v5i0.21473. eCollection 2013.
155. Kolodrubetz D, Spitznagel J, Wang B, Phillips LH, Jacobs C, Kraig E. cis elements and trans factors are both important in strain-specific regulation of the leukotoxin gene in Actinobacillus actinomycetemcomitans. Infect Immun 1996; 64: 3451-60.
156. Kolodrubetz D, Phillips L, Jacobs C, Burgum A, Kraig E. Anaerobic regulation of Actinobacillus actinomycetemcomitans leukotoxin transcription is ArcA/FnrA-independent and requires a novel promoter element. Res Microbiol 2003; 154: 645-53.
157. Childress C, Feuerbacher LA, Phillips L, Burgum A, Kolodrubetz D. Mlc is a transcriptional activator with a key role in integrating cyclic AMP receptor protein and integration host factor regulation of leukotoxin RNA synthesis in Aggregatibacter actinomycetemcomitans. J Bacteriol 2013; 195: 2284-97.
158. Stevens RH, de Moura Martins Lobo Dos Santos C, Zuanazzi D, de Accioly Mattos MB, Ferreira DF, Kachlany SC, et al. Prophage induction in lysogenic Aggregatibacter actinomycetemcomitans cells co-cultured with human gingival fibroblasts, and its effect on leukotoxin release. Microb Pathog 2013; 54: 54-9.
159. Claesson R, Johansson A, Belibasakis G, Hanström L, Kalfas S. Release and activation of matrix metalloproteinase 8 from human neutrophils triggered by the leukotoxin of Actinobacillus actinomycetemcomitans. J Periodontal Res 2002; 37: 353-9.
160. Pütsep K, Carlsson G, Boman HG, Andersson M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 2002; 360: 1144-9.
161. Kantarci AM, Oyaizu K, Van Dyke TE. Neutrophil-mediated tissue injury in periodontal disease pathogenesis: findings from localized aggressive periodontitis. J Periodontol 2003; 74: 66-75.
162. de Haar SF, Hiemstra PS, van Steenbergen MT, Everts V, Beertsen W. Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans. Infect Immun 2006; 74: 5284-91.
163. Carlsson G, Wahlin YB, Johansson A, Olsson A, Eriksson T, Claesson R, et al. Periodontal disease in patients from the original Kostmann family with severe congenital neutropenia. J Periodontol 2006; 77: 744-51.
164. Simpson DL, Berthold P, Taichman NS. Killing of human myelomonocytic leukemia and lymphocytic cell lines by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 1988; 56: 1162-6.
165. Rabie G, Lally ET, Shenker BJ. Immunosuppressive properties of Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 1988; 56: 122-7.
166. Kinane DF, Lappin DF. Immune processes in periodontal disease: a review. Ann Periodontol 2002; 7: 62-71.
167. Ohlrich E, Cullinan M, Seymour G. The immunopathogenesis of periodontal disease. Aust Dent J 2009; 54: S2-S10.
168. Garlet GP. Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints. J Dent Res 2010; 89: 1349-63.
169. Califano JV, Pace BE, Gunsolley JC, Schenkein HA, Lally ET, Tew JG. Antibody reactive with Actinobacillus actinomycetemcomitans leukotoxin in early-onset periodontitis patients. Oral Microbiol Immunol 1997; 12: 20-6.
170. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011; 117: 3720-32.
171. Latz E. The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 2010; 22: 28-33.
172. Kelk P, Abd H, Claesson R, Sandström G, Sjöstedt A, Johansson A. Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxin. Cell Death Dis 2011; 2: e126.
173. Kelk P, Claesson R, Hanstrom L, Lerner UH, Kalfas S, Johansson A. Abundant secretion of bioactive interleukin- 1beta by human macrophages induced by Actinobacillus actinomycetemcomitans leukotoxin. Infect Immun 2005; 73: 453-8.
174. Kelk P, Claesson R, Chen C, Sjostedt A, Johansson A. IL- 1beta secretion induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans is mainly caused by the leukotoxin. Int J Med Microbiol 2008; 298: 529-41.
175. Belibasakis GN, Johansson A. Aggregatibacter actinomycetemcomitans targets NLRP3 and NLRP6 inflammasome expression in human mononuclear leukocytes. Cytokine 2012; 59: 124-30.
176. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010; 327: 2010656-61.
177. Johansson A, Kalfas S. Virulence mechanisms of leukotoxin from Aggregatibacter actinomycetemcomitans. In: Virdi M, ed. Oral health care-prosthodontics, periodontolgy, biology, research and systemic conditions. InTech; 2012.
178. Kimizuka R, Miura T, Okuda K. Characterization of Actinobacillus actinomycetemcomitans hemolysin. Microbiol Immunol 1996; 40: 717-23.
179. Munksgaard PS, Vorup-Jensen T, Reinholdt J, Söderström CM, Poulsen K, Leipziger J, et al. Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes. Cell Microbiol 2012; 14: 1904-20.
180. Skals M, Bjaelde RG, Reinholdt J, Poulsen K, Vad BS, Otzen DE, et al. Bacterial RTX toxins allow acute ATP release from human erythrocytes directly through the toxin pore. J Biol Chem 2014; 289: 19098-109.
181. Smith JL, Bayles DO. The contribution of cytolethal distending toxin to bacterial pathogenesis. Crit Rev Microbiol 2006; 32: 227-48.
182. Jinadasa RN, Bloom SE, Weiss RS, Duhamel GE. Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. Microbiol 2011; 157: 1851-75.
183. Lara-Tejero M, Galán JE. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 2000; 13: 354-7.
184. Elwell CA, Dreyfus LA. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol 2000; 37: 952-63.
185. Belibasakis GN, Johansson A, Wang Y, Chen C, Kalfas S, Lerner U. The cytolethal distending toxin of Actinobacillus actinomycetemcomitans induces RANKL expression by human gingival fibroblasts and periodontal ligament cells. Infect Immun 2005; 73: 342-51.
186. Belibasakis GN, Brage M, Lagergård T, Johansson A. The cytolethal distending toxin up-regulates RANKL expression in Jurkat T-cells. APMIS 2008; 116: 499-506.
187. Schenkein HA. Host responses in maintaining periodontal health and determining periodontal disease. Periodontol 2000 2006; 40: 77-93.
188. Damek-Poprawa M, Haris M, Volgina A, Korostoff J, DiRienzo JM. Cytolethal distending toxin damages the oral epithelium of gingival explants. J Dent Res 2011; 90: 874-9.
189. Damek-Poprawa M, Korostoff J, Gill R, DiRienzo JM. Cell junction remodeling in gingival tissue exposed to a microbial toxin. J Dent Res 2013; 92: 518-23.
190. Sugai M, Kawamoto T, Pérès SY, Ueno Y, Komatsuzawa H, Fujiwara T. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 1998; 66: 5008-19.
191. Shenker BJ, Kushner ME, Tsai CC. Inhibition of fibroblast proliferation by Actinobacillus actinomycetemcomitans. Infect Immun 1982A; 38: 986-92.
192. Shenker BJ, McArthur WP, Tsai CC. Immune suppression induced by Actinobacillus actinomycetemcomitans. I. Effects on human peripheral blood lymphocyte responses to mitogens and antigens. J Immunol B 1982; 128: 148-54.
193. Shenker BJ, Vitale LA, Welham DA. Immune suppression induced by Actinobacillus actinomycetemcomitans: effects on immunoglobulin production by human B cells. Infect Immun 1990; 58: 3856-62.
194. Helgeland K, Nordby O. Cell cycle-specific growth inhibitory effect on human gingival fibroblasts of a toxin isolated from the culture medium of Actinobacillus actinomycetemcomitans. J Periodontal Res 1993; 28: 161-5.
195. Kawamoto D, Ando ES, Longo PL, Nunes AC, WikströmM, Mayer MP. Genetic diversity and toxic activity of Aggregatibacter actinomycetemcomitans isolates. Oral Microbiol Immunol 2009; 24: 493-501.
196. Ahmed HJ, Svensson LA, Cope LD, Latimer JL, Hansen EJ, Ahlman K, et al. Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains. J Med Microbiol 2001; 50: 860-4.
197. Tan KS, Song KP, Ong G. Cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Occurrence and association with periodontal disease. J Periodontal Res 2002; 37: 268-72.
198. Fabris AS, DiRienzo JM, Wïkstrom M, Mayer MP. Detection of cytolethal distending toxin activity and cdt genes in Actinobacillus actinomycetemcomitans isolates from geographically diverse populations. Oral Microbiol Immunol 2002; 17: 231-8.
199. Yamano R, Ohara M, Nishikubo S, Fujiwara T, Kawamoto T, Ueno Y. Prevalence of cytolethal distending toxin production in periodontopathogenic bacteria. J Clin Microbiol 2003; 41: 1391-8.
200. Jentsch H, Cachovan G, Guentsch A, Eickholz P, Pfister W, Eick S. Characterization of Aggregatibacter actinomycetemcomitans strains in periodontitis patients in Germany. Clin Oral Invest 2012; 16: 1589-97.
201. Höglund Åberg C, Antonoglou G, Haubek D, Kwamin F, Claesson R, Johansson A. Cytolethal distending toxin in isolates of Aggregatibacter actinomycetemcomitans from Ghanaian adolescents and association with serotype and disease progression. PLoS One 2013; 8: e65781.
202. Johansson A, Buhlin K, Koski R, Gustafsson A. The immunoreactivity of systemic antibodies to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in adult periodontitis. Eur J Oral Sci 2005; 113: 197-202.
203. Ando ES, De-Gennaro LA, Faveri M, Feres M, DiRienzo JM, Mayer MP. Immune response to cytolethal distending toxin of Aggregatibacter actinomycetemcomitans in periodontitis patients. J Periodontal Res 2010; 45: 471-80.
204. Cortelli SC, Costa FO, Kawai T, Aquino DR, Franco GC, Ohara K, et al. Diminished treatment response of periodontally diseased patients infected with the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans. Clin Microbiol 2009; 47: 2018-25.
205. Sanz M, van Winkelhoff AJ, Herrera D, Dellemijn-Kippuw N, Simón R, Winkel E. Differences in the composition of the subgingival microbiota of two periodontitis populations of different geographical origin. A comparison between Spain and The Netherlands. Eur J Oral Sci 2000; 108: 383-92.
206. van Winkelhoff AJ, Herrera D, Oteo A, Sanz M. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain. J Clin Periodontol 2005; 32: 893-8.
207. Oettinger-Barak O, Dashper SG, Catmull DV, Adams GG, Sela MN, Machtei EE, et al. Antibiotic susceptibility of Aggregatibacter actinomycetemcomitans JP2 in a biofilm. J Oral Microbiol 2013; 5: 10.3402/jom.v5i0.20320. Print 2013.
208. van Winkelhoff AJ, Rodenburg JP, Goené RJ, Abbas F, Winkel EG, de Graaff J. Metronidazole plus amoxycillin in treatment of Actinobacillus actinomycetemcomitans associated periodontitis. J Clin Periodontol 1989; 16: 128-31.
209. van Winkelhoff AJ, Tijhof CJ, de Graaff J. Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis. J Periodontol 1992; 63: 52-7.
210. Saxen L, Asikainen S. Metronidazole in the treatment of localized juvenile periodontitis. J Clin Periodontol 1993; 20: 166-71.
211. Herrera D, Sanz M, Jepsen S, Needleman I, Roldán S. A systematic review on the effect of systematic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 2002; 29: 136-59.
212. Haffajee AD, Socransky SS, Gunsolley JC. Systemic antiinfective periodontal therapy. A systematic review. Ann Periodontol 2003; 8: 115-81.
213. van Winkelhoff AJ. Antibiotics in periodontics: are we getting somewhere? J Clin Periodontol 2005; 32: 1094-5.
214. Yek EC, Cintan S, Topcuoglu N, Kulekci G, Issever H, Kantarci A. Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. J Periodontol 2012; 81: 964-74.
215. Sun R, Kittichotirat W, Wang J, Jan M, Chen W, Asikainen S, et al. Genomic stability of Aggregatibacter actinomycetemcomitans during persistent oral infection in human. PLoS One 2013; 8: 66472.
216. Huang Y, Kittichotirat W, Mayer MP, Hall R, Bumgarner R, Chen C. Comparative genomic hybridization and transcriptome analysis with a pan-genome microarray reveal distinctions between JP2 and non-JP2 genotypes of Aggregatibacter actinomycetemcomitans. Mol Oral Microbiol 2013; 28: 1-17.
217. Zijnge V, Kieselbach T, Oscarsson J. Proteomics of protein secretion by Aggregatibacter actinomycetemcomitans. PLoS One 2012; 7: e41662.
218. Rylev M, Abduljabar AB, Reinholdt J, Ennibi OK, Haubek D, Birkelund S, et al. Proteomic and immunoproteomic analysis of Aggregatibacter actinomycetemcomitans JP2 clone strain HK 1651. J Proteomics 2011; 74: 2972-85.
219. Höglund Åberg C, Haubek D, Kwamin F, Johansson A, Claesson R. Leukotoxic activity of Aggregatibacter actinomycetemcomitans and periodontal attachment loss. PLoS One 2014; 9(8): e104095.
220. Kwamin F, Gref R, Haubek D, Johansson A. Interactions of extracts from selected chewing stick sources with Aggregatibacter actinomycetemcomitans. BMC Res Notes 2012; 5: 203.